Take a walk, beat chemo side effects: new study tests simple exercise breaks

NCT ID NCT06923397

Recruiting now Symptom relief Sponsor: Dana-Farber Cancer Institute Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether a 12-week program of short exercise breaks (walking, cycling, resistance bands) can improve heart health and reduce chemotherapy side effects in 24 newly diagnosed lymphoma patients. Participants will use activity trackers and get coaching to interrupt long periods of sitting. The main goal is to see if the program is feasible and acceptable, with secondary measures of blood sugar and insulin resistance.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: exercise program (walking, cycling, resistance band exercises)
What this could lead to: If it works, this could show that simple exercise breaks during chemo improve heart health and reduce treatment side effects for lymphoma patients.
What could go wrong: This is a small, early feasibility study with only 24 participants, so results may not apply to everyone. The program requires commitment and may be hard for some patients to complete.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LYMPHOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Hodgkins lymphoma lymphoma lymphoma, non-Hodgkin, familial non-Hodgkin lymphoma Sedentary Behavior

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

LYMPHOMA LYMPHOMA, HODGKIN LYMPHOMA, NON-HODGKIN SEDENTARY BEHAVIOR

Contacts and locations

Locations

Dana Farber Cancer Institute
RECRUITING

Boston, Massachusetts, 02215, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.